ArticlePeerJ2023

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.

Monthira Suntiparpluacha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.